Korean Market
OWNR
Dae Hwa Pharm
★

Dae Hwa Pharm Non-Registered Executive Bang Sin-won Acquires 1,000 Shares via Open Market Purchase... Small Buy Signals Management Interest

 
OWNR
Dae Hwa Pharm
★

CEO Kim Eun-seok Increases Stake to 1.14% via Open Market Purchase... Limited Signal of Management Confidence

 
PERI
Dae Hwa Pharm
★★

Daehwa Pharmaceutical: Liporaxel Breast Cancer Approval and Q1 Results

 
OWNR
Dae Hwa Pharm
★

Insider and Major Shareholder Holdings Report (No Change)

 
EXCH
Dae Hwa Pharm
★★★★

Liporaxel (Paclitaxel) Gains Approval for New Breast Cancer Indication